دورية أكاديمية

Oral Metformin Treatment Prevents Enhanced Insulin Demand and Placental Dysfunction in the Pregnant Rat Fed a Fructose-Rich Diet.

التفاصيل البيبلوغرافية
العنوان: Oral Metformin Treatment Prevents Enhanced Insulin Demand and Placental Dysfunction in the Pregnant Rat Fed a Fructose-Rich Diet.
المؤلفون: Alzamendi, Ana, Zotto, Hector Del, Castrogiovanni, Daniel, Romero, Jose, Giovambattista, Andres, Spinedi, Eduardo
المصدر: ISRN Endocrinology; 2012, p1-8, 8p
مصطلحات موضوعية: ACADEMIC medical centers, ANALYSIS of variance, ANIMAL experimentation, GESTATIONAL diabetes, FISHER exact test, FRUCTOSE, HEALTH outcome assessment, RATS, RESEARCH funding, STATISTICS, DATA analysis, TREATMENT effectiveness, METFORMIN
مصطلحات جغرافية: ARGENTINA
مستخلص: The intake of a fructose-rich diet (FRD) in the normal female rat induces features similar to those observed in the human metabolic syndrome phenotype. We studied the impact of FRD administration to mothers on pregnancy outcome. On gestational day (Gd) zero rats were assigned to either group: ad libitum drinking tap water alone (normal diet, ND) or containing fructose (10% w/vol; FRD) through pregnancy; all rats were fed a Purina chow diet ad libitum ND and FRD rats were daily cotreated or not with metformin (60 mg/Kg/day oral; ND + MF and FRD + MF) and submitted to a high glucose load test on Gd 14. Additionally, placentas from different groups were studied on Gd 20. Data indicated that: (1) although FRD rats well tolerated glucose overload, their circulating levels of insulin were significantly higher than in ND rats; (2) the mesometrial triangle blood vessel area was significantly lower in placentas from FRD than ND dams; (3) the detrimental effects of FRD administration to mothers were ameliorated by metformin cotreatment. Our study suggests that excessive intake of fructose during pregnancy enhanced the risk for developing gestational diabetes and subsequent preeclampsia, and that metformin prevented the poor pregnancy outcome induced by FRD. [ABSTRACT FROM AUTHOR]
Copyright of ISRN Endocrinology is the property of Hindawi Limited and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
قاعدة البيانات: Complementary Index
الوصف
تدمد:20904630
DOI:10.5402/2012/757913